Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-034257
Filing Date
2025-11-12
Accepted
2025-11-12 08:43:06
Documents
1
Period of Report
2025-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4083
  Complete submission text file 0001437749-25-034257.txt   5468
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
te Boekhorst Paul Francis Olivier (Reporting) CIK: 0002095704 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 251469401